In a study conducted by El-Sayed and colleagues,24 it was shown that mRNA transcripts as well as percentages of FoxP3 were significantly increased in B-cell NHL patients before receiving CHOP, when compared to healthy controls. The gene discussed is FOXP3; the disease is B-cell non-Hodgkin lymphoma.